Shelton Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-3,633
Closed -$202K 879
2017
Q1
$202K Sell
3,633
-4,425
-55% -$244K 0.01% 816
2016
Q4
$420K Hold
8,058
0.03% 443
2016
Q3
$389K Buy
8,058
+3,633
+82% +$184K 0.03% 468
2016
Q2
$245K Hold
4,425
0.02% 635
2016
Q1
$236K Buy
4,425
+293
+7% +$14.4K 0.02% 653
2015
Q4
$213K Buy
+4,132
New +$205K 0.02% 684

Other funds holding PBH

Shelton Capital Management's PBH Position: Q2 2017 in Review

Shelton Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q2 2017, closing a stake of 3,633 shares — an estimated $202K sold.

Shelton Capital Management first reported a position in PBH in Q4 2015 and held it in 6 quarters. The position peaked at $420K in Q4 2016. 232 funds tracked by Wall St. Rank hold PBH as of Q2 2017.

  • Shelton Capital Management reported no remaining Prestige Consumer Healthcare position as of Q2 2017 after selling out during the quarter.
  • Shelton Capital Management sold 3,633 Prestige Consumer Healthcare shares in Q2 2017, an estimated $202K.
  • Shelton Capital Management first reported a position in Prestige Consumer Healthcare in Q4 2015 and held it in 6 quarters.
  • Shelton Capital Management's Prestige Consumer Healthcare position peaked at $420K in Q4 2016.
  • 232 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2017.

Based on Shelton Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.